BAA contract titled, "wireless pharmaceutical analysis device (wpad) and computational model to determine in vivo drug dissolution in GI tract for distinguishing meaningful product differences and…
Ended Definitive Contract Awarded Last action
- Contract number
- HHSF223201510146C
- Awardee
-
Regents Of The University Of Michigan UEI GNJ7BBP73WE9
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,558,077
Award facts
- Opportunity
-
- FDABAA1500121 Solicitation number
- Food and Drug Administration Broad Agency Announcement for the Advanced Research and Development of Regulatory Science Award Notice · Posted Feb 23, 2015
- Contract value 40% obligated
-
- $2,558,077.39 Current, with exercised options
- $6,343,667.39 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 12 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Ann Arbor, MI 48109, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$21,353 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $479,430 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,100,000 |
About this award
This is a federal contract award from the Food and Drug Administration (FDA) to the Regents of the University of Michigan (University of Michigan) for the development of a "Wireless Pharmaceutical Analysis Device (WPAD) and Computational Model to Determine In Vivo Drug Dissolution in GI Tract for Distinguishing Meaningful Product Differences and Ensuring Bioequivalence." The contract is a definitive contract with a cost-no-fee pricing type and has a ceiling value of $6,343,667.39. The contract has an ultimate completion date of August 31, 2020. The University of Michigan is the prime contractor, and there is no set-aside designation mentioned. The University of Michigan has a history of receiving federal contracts and grants from agencies such as the Department of Veterans Affairs, National Institutes of Health, and National Science Foundation for research and development activities.
Description
BAA contract titled, "wireless pharmaceutical analysis device (wpad) and computational model to determine in vivo drug dissolution in GI tract for distinguishing meaningful product differences and ensuring bioequivalence."
Quick answers
Who was awarded contract HHSF223201510146C?
HHSF223201510146C was awarded to Regents Of The University Of Michigan by Food and Drug Administration (Department of Health and Human Services) on September 11, 2015.
How much is contract HHSF223201510146C worth?
The government has obligated $2,558,077 on HHSF223201510146C. Its potential value, with all options, is $6,343,667.
Was contract HHSF223201510146C competed?
The extent of competition for HHSF223201510146C was full and open competition. The government received 12 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award